HOT NEWS
Merck KGaA
Merck KGaAMerck is a global pharmaceutical and chemical company with total revenues of € 7.1 billion in 2007, a history that began in 1668, and a future shaped by 32,458 employees in 59 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since. For more information, please visit http://www.merck.de.

Merck KGaA RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Merck KGaA's Cladribine Tablets for MS Approved in Russia 967
2 Q1/2010: Merck Net Profit After Tax More Than Triples 984
3 FY2009: Merck KGaA Revenues Rise by 2.1% to € 7.7 Billion 1105
4 New Data From CLARITY Study on Disease Activity in MS Patients 1771
5 Merck KGaA Submits Application for Cladribine Tablets as Multiple Sclerosis Therapy in Europe 1651
6 Q1/2009: Merck Revenues Remain Stable at € 1.9 Billion 1200
7 Annual General Meeting of Merck KGaA: Shareholders Approve Dividend of € 1.50 per Share 1416
8 Merck KGaA Launches Strategic Venture Capital Fund 1378
9 Merck KGaA and Fast Forward, LLC Announce Collaboration 1395
10 The safety of patients is of utmost importance to Merck 1666
11 Merck: 2008 Operating Result Rises 16% to € 1,131 Million 1029
12 Oral Investigational Multiple Sclerosis Treatment to Complete a Two-Year Pivotal Study 817
13 Merck KGaA and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics 917
14 Merck KGaA's Kuvan Receives Marketing Authorization in Europe 887
15 Merck KGaA Acquires Bio-Fyt Pharma in Belgium 979
 
Bookmark and Share